Thursday, February 22nd, 2018
The New Jersey Innovation Institute, an NJIT corporation, is collaborating with Celgene Corporation, a global biopharmaceutical company, to train its workforce in the manufacture of a new generation of cell therapy technologies to be produced in Celgene’s facilities in Warren and Summit, NJ.